vs

Side-by-side financial comparison of HARROW, INC. (HROW) and INSTEEL INDUSTRIES INC (IIIN). Click either name above to swap in a different company.

INSTEEL INDUSTRIES INC is the larger business by last-quarter revenue ($159.9M vs $89.1M, roughly 1.8× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 4.7%, a 2.7% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 23.3%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-2.2M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 12.0%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.

HROW vs IIIN — Head-to-Head

Bigger by revenue
IIIN
IIIN
1.8× larger
IIIN
$159.9M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+10.0% gap
HROW
33.3%
23.3%
IIIN
Higher net margin
HROW
HROW
2.7% more per $
HROW
7.4%
4.7%
IIIN
More free cash flow
HROW
HROW
$10.3M more FCF
HROW
$8.1M
$-2.2M
IIIN
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
12.0%
IIIN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
IIIN
IIIN
Revenue
$89.1M
$159.9M
Net Profit
$6.6M
$7.6M
Gross Margin
79.3%
11.3%
Operating Margin
17.5%
6.0%
Net Margin
7.4%
4.7%
Revenue YoY
33.3%
23.3%
Net Profit YoY
-2.2%
602.4%
EPS (diluted)
$0.20
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
IIIN
IIIN
Q4 25
$89.1M
$159.9M
Q3 25
$71.6M
$177.4M
Q2 25
$63.7M
$179.9M
Q1 25
$47.8M
$160.7M
Q4 24
$66.8M
$129.7M
Q3 24
$49.3M
$134.3M
Q2 24
$48.9M
$145.8M
Q1 24
$34.6M
$127.4M
Net Profit
HROW
HROW
IIIN
IIIN
Q4 25
$6.6M
$7.6M
Q3 25
$1.0M
$14.6M
Q2 25
$5.0M
$15.2M
Q1 25
$-17.8M
$10.2M
Q4 24
$6.8M
$1.1M
Q3 24
$-4.2M
$4.7M
Q2 24
$-6.5M
$6.6M
Q1 24
$-13.6M
$6.9M
Gross Margin
HROW
HROW
IIIN
IIIN
Q4 25
79.3%
11.3%
Q3 25
75.3%
16.1%
Q2 25
74.5%
17.1%
Q1 25
67.5%
15.3%
Q4 24
78.8%
7.3%
Q3 24
75.6%
9.1%
Q2 24
74.4%
10.6%
Q1 24
69.5%
12.3%
Operating Margin
HROW
HROW
IIIN
IIIN
Q4 25
17.5%
6.0%
Q3 25
20.6%
10.8%
Q2 25
17.9%
11.0%
Q1 25
-23.5%
8.3%
Q4 24
19.3%
1.1%
Q3 24
2.7%
4.5%
Q2 24
3.1%
6.0%
Q1 24
-20.0%
7.0%
Net Margin
HROW
HROW
IIIN
IIIN
Q4 25
7.4%
4.7%
Q3 25
1.4%
8.2%
Q2 25
7.8%
8.4%
Q1 25
-37.2%
6.4%
Q4 24
10.1%
0.8%
Q3 24
-8.6%
3.5%
Q2 24
-13.2%
4.5%
Q1 24
-39.2%
5.4%
EPS (diluted)
HROW
HROW
IIIN
IIIN
Q4 25
$0.20
$0.39
Q3 25
$0.03
$0.74
Q2 25
$0.13
$0.78
Q1 25
$-0.50
$0.52
Q4 24
$0.19
$0.06
Q3 24
$-0.12
$0.24
Q2 24
$-0.18
$0.34
Q1 24
$-0.38
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
IIIN
IIIN
Cash + ST InvestmentsLiquidity on hand
$72.9M
$15.6M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$358.8M
Total Assets
$399.5M
$456.1M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
IIIN
IIIN
Q4 25
$72.9M
$15.6M
Q3 25
$74.3M
$38.6M
Q2 25
$53.0M
$53.7M
Q1 25
$66.7M
$28.4M
Q4 24
$47.2M
$36.0M
Q3 24
$72.6M
$111.5M
Q2 24
$71.0M
$97.7M
Q1 24
$76.0M
$83.9M
Total Debt
HROW
HROW
IIIN
IIIN
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
IIIN
IIIN
Q4 25
$52.4M
$358.8M
Q3 25
$47.0M
$371.5M
Q2 25
$49.7M
$356.2M
Q1 25
$56.5M
$341.4M
Q4 24
$69.7M
$331.6M
Q3 24
$58.0M
$350.9M
Q2 24
$58.5M
$346.0M
Q1 24
$60.6M
$340.6M
Total Assets
HROW
HROW
IIIN
IIIN
Q4 25
$399.5M
$456.1M
Q3 25
$363.1M
$462.6M
Q2 25
$345.0M
$471.9M
Q1 25
$364.2M
$421.9M
Q4 24
$389.0M
$404.7M
Q3 24
$351.5M
$422.6M
Q2 24
$306.6M
$414.6M
Q1 24
$295.5M
$397.2M
Debt / Equity
HROW
HROW
IIIN
IIIN
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
IIIN
IIIN
Operating Cash FlowLast quarter
$8.4M
$-701.0K
Free Cash FlowOCF − Capex
$8.1M
$-2.2M
FCF MarginFCF / Revenue
9.1%
-1.4%
Capex IntensityCapex / Revenue
0.4%
0.9%
Cash ConversionOCF / Net Profit
1.27×
-0.09×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$439.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
IIIN
IIIN
Q4 25
$8.4M
$-701.0K
Q3 25
$16.6M
$-17.0M
Q2 25
$-803.0K
$28.5M
Q1 25
$19.7M
$-3.3M
Q4 24
$-17.8M
$19.0M
Q3 24
$3.0M
$16.2M
Q2 24
$-2.7M
$18.8M
Q1 24
$-4.6M
$1.4M
Free Cash Flow
HROW
HROW
IIIN
IIIN
Q4 25
$8.1M
$-2.2M
Q3 25
$16.4M
$-18.7M
Q2 25
$-969.0K
$26.9M
Q1 25
$19.5M
$-5.5M
Q4 24
$-18.3M
$16.3M
Q3 24
$2.3M
$14.5M
Q2 24
$-3.1M
$15.5M
Q1 24
$-4.7M
$-580.0K
FCF Margin
HROW
HROW
IIIN
IIIN
Q4 25
9.1%
-1.4%
Q3 25
22.9%
-10.6%
Q2 25
-1.5%
15.0%
Q1 25
40.8%
-3.5%
Q4 24
-27.4%
12.6%
Q3 24
4.8%
10.8%
Q2 24
-6.3%
10.7%
Q1 24
-13.6%
-0.5%
Capex Intensity
HROW
HROW
IIIN
IIIN
Q4 25
0.4%
0.9%
Q3 25
0.3%
1.0%
Q2 25
0.3%
0.9%
Q1 25
0.4%
1.4%
Q4 24
0.8%
2.1%
Q3 24
1.2%
1.3%
Q2 24
0.7%
2.2%
Q1 24
0.3%
1.5%
Cash Conversion
HROW
HROW
IIIN
IIIN
Q4 25
1.27×
-0.09×
Q3 25
16.26×
-1.17×
Q2 25
-0.16×
1.88×
Q1 25
-0.32×
Q4 24
-2.62×
17.56×
Q3 24
3.48×
Q2 24
2.86×
Q1 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

IIIN
IIIN

Welded Wire Reinforcement$108.4M68%
PC Strand$51.6M32%

Related Comparisons